Rischke J - Search Results

1

Healing Hands: The Tactile Internet in Future Tele-Healthcare.

Senk S, Ulbricht M, Tsokalo I, Rischke J, Li SC, Speidel S, Nguyen GT, Seeling P, Fitzek FHP. Senk S, et al. Among authors: rischke j. Sensors (Basel). 2022 Feb 11;22(4):1404. doi: 10.3390/s22041404. Sensors (Basel). 2022. PMID: 35214306 Free PMC article.

2

Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.

Schaefer AV, Leslie BA, Rischke JA, Stafford AR, Fredenburgh JC, Weitz JI. Schaefer AV, et al. Among authors: rischke ja. Biochemistry. 2006 Apr 4;45(13):4257-65. doi: 10.1021/bi0525730. Biochemistry. 2006. PMID: 16566600

3

In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.

Linkins LA, Julian JA, Rischke J, Hirsh J, Weitz JI. Linkins LA, et al. Among authors: rischke j. Thromb Res. 2002 Sep 1;107(5):241-4. doi: 10.1016/s0049-3848(02)00340-7. Thromb Res. 2002. PMID: 12479885

4

Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.

Lee AY, Fredenburgh JC, Stewart RJ, Rischke JA, Weitz JI. Lee AY, et al. Among authors: rischke ja. Thromb Haemost. 2001 Mar;85(3):502-8. Thromb Haemost. 2001. PMID: 11307822

5

Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.

Stewart RJ, Fredenburgh JC, Rischke JA, Bajzar L, Weitz JI. Stewart RJ, et al. Among authors: rischke ja. J Biol Chem. 2000 Nov 24;275(47):36612-20. doi: 10.1074/jbc.M005483200. J Biol Chem. 2000. PMID: 10970891 Free article.

6

Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.

Stewart RJ, Fredenburgh JC, Leslie BA, Keyt BA, Rischke JA, Weitz JI. Stewart RJ, et al. Among authors: rischke ja. J Biol Chem. 2000 Apr 7;275(14):10112-20. doi: 10.1074/jbc.275.14.10112. J Biol Chem. 2000. PMID: 10744692 Free article.

7

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.

Cosmi B, Fredenburgh JC, Rischke J, Hirsh J, Young E, Weitz JI. Cosmi B, et al. Among authors: rischke j. Circulation. 1997 Jan 7;95(1):118-24. doi: 10.1161/01.cir.95.1.118. Circulation. 1997. PMID: 8994426

8

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers.

Rainsford KD, James C, Hunt RH, Stetsko PI, Rischke JA, Karim A, Nicholson PA, Smith M, Hantsbarger G. Rainsford KD, et al. Among authors: rischke ja. Clin Pharmacol Ther. 1992 Apr;51(4):415-21. doi: 10.1038/clpt.1992.41. Clin Pharmacol Ther. 1992. PMID: 1563211 Clinical Trial.

9

The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis.

Kean WF, Antal EJ, Grace EM, Cauvier H, Rischke J, Buchanan WW. Kean WF, et al. Among authors: rischke j. J Clin Pharmacol. 1992 Jan;32(1):41-8. doi: 10.1002/j.1552-4604.1992.tb03786.x. J Clin Pharmacol. 1992. PMID: 1740536 Clinical Trial.

10

Action of gold sodium thiomalate on experimental thrombosis in vivo.

Kean WF, Lock CJ, Somers D, Rischke J, Nablo L, Kassam YB, Hogan MG, Buchanan WW, Howard-Lock HE. Kean WF, et al. Among authors: rischke j. J Pharm Sci. 1991 Feb;80(2):113-8. doi: 10.1002/jps.2600800205. J Pharm Sci. 1991. PMID: 1904936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page